Poland· PL-100499353
Xifia
A cefixime product containing cefiximum, registered in Poland by INN-FARM d.o.o.,. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cefixime is registered in 13 of 19 countries.
Countries holding a registration under ATC J01DD08 (cefixime), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Cefixime · ATC J01DD08
13 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefixime costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.31 in Spain to $2.20 in Italy — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefixime · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- IT Italy$2.20
- ES Spain$1.31
The record
At a glance
URPL (Poland)- Active substance
- Cefiximum
- Manufacturer
- INN-FARM d.o.o.,
- Country
- Poland (PL)
- ATC code
- J01DD08
- ATC class
- Cefixime
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991594664
- gtin05909991594671
- gtin05909991594688
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
21 interactions on record for cefixime.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefixime · interactions on record
21 records
- 20 moderate
- 1 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefixime in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyCEFIXIMA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- CzechiaCEFIXIME INNFARMINN-FARM d.o.o., Ljubljana
- SpainAFIXORA 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGCodal-Synto Limited
- NorwayCefixime MedochemieMedochemie Ltd
- SwedenCefixime Medochemie 400 mg Filmdragerad tablettMedochemie Ltd
- United StatesCefiximeAurobindo Pharma Limited
- FranceCEFIXIME ALMUS 200 mg, comprimé pelliculéBIOGARAN
- GermanyCefixim AlAliud Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Cefixim Nectar, Sorcelif
- Bulgaria · Cefixime Neclife, Cefixime Viatris
- Cyprus · Cefimed, Cefixime Viatris
- Czechia · Cefixime Innfarm, Sorcelif
- Germany · Cefixim Al, Cefixim Aristo
- Spain · Afixora, Cefixima Neclife
- France · Cefixime Almus, Cefixime Arrow
- United Kingdom (Northern Ireland) · Suprax
- Greece · Ceftoral
- Croatia · Cefiksim Alkaloid, Cefiksim Nectar
- Hungary · Cefixim Nectar, Cefixime Reiwa Healthcare
- Ireland · Cefixime Nectar Lifesciences, Suprax
- Italy · Cefixima Aurobindo, Cefixima Doc Generici
- Lithuania · Cefixime Medochemie
- Malta · Tricef
- Norway · Cefixime Frostpharma, Cefixime Medochemie
- Portugal · Cefiton, Cefixim Nectar
- Romania · Axtrifia, Cefiximă Medochemie
- Sweden · Cefixime Frostpharma, Cefixime Medochemie
- Slovenia · Pancef
- Slovakia · Cefimed, Cefixim
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/00cb9ab7-ef2d-41bc-844e-d982efdf4ee3 GET /v1/drugs/00cb9ab7-ef2d-41bc-844e-d982efdf4ee3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "400 mg",
"packaging": "05909991594664 ¦ Rp ¦ 165868\n5 tabl.\n05909991594671 ¦ Rp ¦ 165869\n7 tabl.\n05909991594688 ¦ Rp ¦ 165870\n10 tabl.",
"substance": "Cefiksymu trójwodzian 447.63 mg",
"common_name": "Cefiximum",
"pl_product_id": "100499353",
"pozwolenie_nr": "29539",
"auth_procedure": "DCP",
"authorisation_validity": "2031-02-19"
}See everything about cefixime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.